多种介入结合中医综合治疗肝癌的探索  

Explore the multimodality treatment of hepatocarcinoma with various kinds of intervention and Traditional Chinese Medicine

作　　者：张正信 鲁邦卫 

机构地区：[1]湖南省湘西州肿瘤医院,416000

出　　处：《健康必读（下）》2011年第1期31-32,共2页

摘　　要：目的：探索综合介入治疗结合中医治疗原发及转移性肝癌的效果.方法：43例无明确介入治疗禁忌症的肝癌,采用DSA引导下TACE（经肝动脉化疗栓塞）,CT引导下PEI（经皮化学消融）、PMCT（经皮微波消融）综合治疗.部分TACE术前术后结合中医治疗.结果：全组平均生存时间21个月.累积1年、2年生存率分别为85%、60%.结论：综合介入治疗是原发性及转移性肝癌的安全、有效治疗方法,结合中医治疗可明显减轻不良反应,延长患者的生存时间,改善生活质量.Objective：To explore the therapeutic effect of hepatoearcinoma with comprehensive intervention and Traditional Chinese Medicine. Methods：43 patients with hepatocarcinoma who had no clear interventional treatment contraindieations were assigned to multimodality treatment, using TACE （transeatherter arterial chemoembolization） under the guidance of DSA（digital subtraction angiography） ,PEI （Pereutanous et hanoi injection） under the guidance of CT, PMCT （Percutaneous microwave coagulation therapy）. Part of TACE combined with Chinese medicine treatment before and after surgery. Results：The median survival of the whole group was 21 months. Cumulative 1-year, 2-year survival was 85%, 60%,respectively. Conclusion： comprehensive intervention treatment is a safe and effective method in the treatment of patients with primary and metastatic hepatocarcinoma, combined with Chinese medicine treatment can significantly reduce adverse reactions, prolong the survival time of patients and improve quality of life.

关 键 词：肝癌 TACE PMCT PEI 中医治疗 

分 类 号：R735.7[医药卫生—肿瘤]